Vivex Biologics, a leader in developing and delivering innovative allografts, today announced the publication of a new real-world evidence study demonstrating that VIA Disc® NP significantly reduces ...
An injection that relieves low back pain by helping damaged spinal discs regenerate appears to have sustained benefits, new clinical trial data show. Most patients who received an injection of VIA ...
MIAMI, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, a leader in developing and delivering innovative allografts, today announced that it has treated the first patient in its Restore U.S.
Claimant, who had a work-related lumbar spine injury, relocated to South Carolina and was recommended for VIA disc injections by his new physician. Respondents denied the procedure, citing a lack of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results